Koninklijke Philips (NYSE:PHG) Downgraded by StockNews.com to Hold

StockNews.com lowered shares of Koninklijke Philips (NYSE:PHG) from a buy rating to a hold rating in a report published on Monday morning.

A number of other brokerages have also weighed in on PHG. BNP Paribas raised shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a report on Tuesday, March 18th. Finally, UBS Group raised shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

Koninklijke Philips Stock Down 0.7%

Koninklijke Philips stock opened at $23.85 on Monday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.74 and a current ratio of 1.23. The stock’s fifty day moving average is $24.52 and its two-hundred day moving average is $25.72. Koninklijke Philips has a fifty-two week low of $21.48 and a fifty-two week high of $32.91. The firm has a market capitalization of $22.42 billion, a price-to-earnings ratio of -28.39, a price-to-earnings-growth ratio of 0.82 and a beta of 0.81.

Koninklijke Philips (NYSE:PHG) last announced its earnings results on Tuesday, May 6th. The technology company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.13. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The firm had revenue of $4.31 billion for the quarter, compared to analyst estimates of $4.10 billion. During the same quarter last year, the business earned $0.21 earnings per share. Koninklijke Philips’s revenue was down 1.0% compared to the same quarter last year. Analysts predict that Koninklijke Philips will post 1.63 EPS for the current fiscal year.

Koninklijke Philips Cuts Dividend

The business also recently declared an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be issued a dividend of $0.886 per share. This represents a dividend yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s dividend payout ratio is currently 174.42%.

Institutional Trading of Koninklijke Philips

A number of institutional investors have recently bought and sold shares of PHG. Colonial Trust Co SC increased its holdings in shares of Koninklijke Philips by 724.0% during the 4th quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company’s stock valued at $36,000 after acquiring an additional 1,238 shares during the last quarter. Bessemer Group Inc. raised its stake in shares of Koninklijke Philips by 2,935.4% in the first quarter. Bessemer Group Inc. now owns 1,973 shares of the technology company’s stock valued at $51,000 after purchasing an additional 1,908 shares in the last quarter. Farther Finance Advisors LLC raised its position in Koninklijke Philips by 37.1% in the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock worth $54,000 after purchasing an additional 582 shares in the last quarter. Whipplewood Advisors LLC acquired a new stake in Koninklijke Philips during the fourth quarter valued at approximately $55,000. Finally, Millstone Evans Group LLC acquired a new stake in Koninklijke Philips during the fourth quarter valued at approximately $60,000. Institutional investors and hedge funds own 13.67% of the company’s stock.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.